Join Omixon for our Vendor Presentation at the NGS Workshop in Dallas

09/11/2016

We are proud to be one of the Vendors of this year’s ASHI NGS Workshop in Dallas, Texas. Dr. Peter Meintjes, CCO at Omixon will give a Vendor Presentation titled “Omixon: Holotype HLA V2” Date and time: Friday, November 11, 2:00pm-2:30pm CST Venue: Embassy Suites by Hilton Dallas – DFW Airport...

PLOS ONE: Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment Samples

04/11/2016

Authors: Yuxin Yin, James H. Lan, David Nguyen, Nicole Valenzuela, Ping Takemura, Yung-Tsi Bolon, Brianna Springer, Katsuyuki Saito, Ying Zheng, Tim Hague, Agnes Pasztor, Gyorgy Horvath, Krisztina Rigo, Elaine F. Reed, Qiuheng Zhang Abstract: Background Unambiguous HLA typing is important in hematopoietic stem cell transplantation (HSCT), HLA disease association studies, and solid organ transplantation. However, current molecular typing methods only...

Alp Şen Foundation Ignite Registry Typing by NGS in Turkey

27/10/2016

Omixon today announce that Holotype HLA, the world’s leading NGS-based product for HLA genotyping has been selected and implemented by the Alp Şen Foundation in Turkey as the HLA genotyping solution of choice. Supply of Holotype HLA will officially be provided through GenPlus, Omixon’s distributor in Turkey – financial details...

Fishing for Reads – HLA Typing From Non-targeted Data

26/10/2016

What is non-targeted data? For the sake of this post, ‘non-targeted data’ will be used as a collective term for data with more than a dozen or so targeted genes. Whole exome or whole genome sequencing, whole MHC, or multi-gene panels all fall into this category. These data types...

Omixon “Rode the Bull” Again – ASHI, 2016

07/10/2016

Following on from the trends set last year, eight excited members of the Omixon Team went on a trip to outride the best in the rodeo of ASHI 2016 in St. Louis, MO. Thanks to One Lambda for including a mechanical bull to literally let the bull-times ride! Although...